ClinicalTrials.gg
RecruitingNCT06865872Updated Oct 28, 2025

Alcohol and Sexual Communication Among Couples in the Laboratory

An interventional study of Direct Communication and Indirect Communication in Alcohol Intoxication, Intimate Partner Violence (IPV) and Communication, sponsored by University of Colorado, Denver. Recruiting at 1 site in United States. Open to participants aged 21 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-28.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
480
Allocation
Randomized
Ages
21 Years to 65 Years
Sex
All
01

Study summary

Intimate Partner Sexual Violence (IPSV) is a significant and understudied public health problem among couples, yet little is known about factors that contribute to IPSV perpetration. This proposal aims to determine the acute effect of alcohol and sexual communication on IPSV. In this study, 240 couples who drink alcohol will be recruited from the Metro-Denver area. Upon arrival to the laboratory, a trained research assistant will check the participant's ID, verify that they adhered to the pre-session guidelines, administer a breath test to ensure a breath alcohol content (BrAC) of 0.00 and conduct a field sobriety test. They will also obtain informed consent for each member of the couple separately. Female participants will take a pregnancy test to ensure a negative result. All participants will complete measures to reverify eligibility criteria and be weighed to determine their correct alcohol dose. Partners will separately complete a baseline survey measuring demographic factors, alcohol use, sexual communication, and daily experiences. After completing the survey, participants will be assigned a beverage condition (alcohol or no-alcohol control) and couples will be randomly assigned to a communication condition (direct verbal or indirect verbal). Participants will be seated in a room separate from their partner, where they will drink an alcoholic or no-alcohol control beverage. Upon reaching a breath alcohol content (BrAC) of .07, or immediately after drinking in the No-Alcohol control condition, participants will complete a laboratory assessment of sexual violence. The main hypotheses are: (1) one's alcohol use will increase IPSV toward partners who are also drinking, (2) one's alcohol use will increase IPSV among partners who use indirect, relative to direct, communication, and (3) actor alcohol use will increase IPSV toward partners who are also drinking and use indirect, relative to direct, communication.

02

Conditions studied

  • Alcohol Intoxication
  • Intimate Partner Violence (IPV)
  • Communication
03

In context

Alcoholic Intoxication

76 studies on the registry are indexed under Alcoholic Intoxication; 17 are open to participants now.

This study's planned enrollment of 480 is above the median of 135 across 62 interventional studies indexed under Alcoholic Intoxication.

Browse Alcoholic Intoxication studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,543 studies on the registry; 317 are open to participants now.

Of its 147 completed or terminated interventional studies of FDA-regulated products, 92 (63%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Provision of signed and dated form.
  2. Stated willingness to comply with all study procedures and lifestyle considerations.
  3. Both partners must identify as cisgender via self-report on the Baseline Questionnaire.
  4. At least one partner within the couple must be a man via self-report on the Baseline Questionnaire.
  5. Both partners must be between 21 and 65 years old, verified by a photo ID.
  6. In an intimate relationship lasting at least one month in which they engaged in sexual activity at least once in the past month with their partner via self-report on the Baseline Questionnaire.
  7. Both partners must report that they consumed a weight-based amount of alcohol that is equal to or greater than the dose to be administered in the lab at least three times during the past year via self-report on question #5 of the NIAAA Alcohol Consumption Measure.

Please contact clinical site for additional inclusion criteria.

Exclusion criteria

Exclusion Criteria:

  1. Treatment for Alcohol or Drug Use: currently being treated for alcohol, or drug problems; currently interested in seeking treatment for drinking or drug use via self-report.
  2. Any medical or psychiatric condition, as well as current use of a medication, that would contraindicate alcohol administration via self-report:

    • Cardiac Pacemaker
    • Asthma: emergency room visit related to asthma in the past year; use of inhaler more frequently when drinking alcohol; use of oral treatments for asthma in the past year
    • Head Injury: any past serious head injuries
    • Acute Psychiatric Symptomatology: elevated psychological distress as indicated by a score greater than 65 on the Brief Symptom Inventory
  3. Self-report that a participant is trying to get pregnant, currently pregnant, or currently breastfeeding or a positive pregnancy test.
  4. Combined height and weight that is either less than 6 feet tall and over 230 lbs, or over 250 lbs and over 6 ft tall as measured during the lab visit.

Please contact clinical site for additional exclusion criteria.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
480 participants (estimated)

Study arms

  • Experimental
    Alcohol Consumption + Direct Communication

    Participants will be assigned to drink alcohol and to receive direct communication about their sexual preferences from their partner.

    Other: Direct Communication · Drug: Alcohol (Ethanol)

  • Experimental
    Alcohol Consumption + Indirect Communication

    Participants will be assigned to drink alcohol and to receive indirect communication about their sexual preferences from their partner.

    Other: Indirect Communication · Drug: Alcohol (Ethanol)

  • Experimental
    No Alcohol + Direct Communication

    Participants will be assigned to drink a no-alcohol control beverage and to receive direct communication about their sexual preferences from their partner.

    Other: Direct Communication · Other: No-Alcohol Control

  • Experimental
    No Alcohol + Indirect Communication

    Participants will be assigned to drink a no-alcohol control beverage and to receive indirect communication about their sexual preferences from their partner.

    Other: Indirect Communication · Other: No-Alcohol Control

Interventions

  • OtherDirect Communication

    Participants assigned to receive direct communication about their sexual preferences from their partner.

  • OtherIndirect Communication

    Participants assigned to receive indirect communication about their sexual preferences from their partner.

  • Participants assigned to moderate alcohol dose condition (target BrAC .10%) with the National Institute on Alcohol Abuse and Alcoholism (NIAAA) approved alcohol administration procedures.

  • OtherNo-Alcohol Control

    Participants assigned to a no-alcohol control beverage.

06

What researchers measure

Primary outcomes

  1. Sexual Violence Perpetration as Measured by the Sexual Imposition Paradigm

    The Sexual Imposition Paradigm measures sexual violence perpetration. Possible scores are 0 (no perpetration) to 1 (perpetration).

    Time frame: up to 1 hour post beverage consumption

  2. Sexual Violence Perpetration Length of Time as Measured by the Sexual Imposition Paradigm

    The Sexual Imposition Paradigm measures sexual violence perpetration length of time. Scores range from 0 to 120 seconds, with higher scores indicating longer perpetration.

    Time frame: up to 1 hour post beverage consumption

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — IPD will be available in the NIAAA Data Archive.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Feb 2028, 34 months after the start.

Of 29 interventional studies with no phase under Alcoholic Intoxication, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 58. This study's planned 34 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2025
First posted
Mar 10, 2025
StartActual
Apr 18, 2025
Primary completionEst.
Feb 2028
CompletionEst.
Feb 2028
Last update
Oct 28, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06865872
Responsible party
Sponsor
First posted
Mar 10, 2025
Start date
Apr 18, 2025
Primary completion
Feb 2028 (estimated)
Completion
Feb 2028 (estimated)
Last update
Oct 28, 2025

Study contacts

Ruschelle M Leone, PhD
Contact
ruschelle.leone@cuanschutz.edu
303-724-7052

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Ethanol

Start the discussion